Section 7 Request

Under the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless it displays a valid OMB control number. PTO Form 1597 (Rev 11/2007)

OMB No. 0651-0055 (Exp 10/31/2021)

---

Under the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless it displays a valid OMB control number. PTO Form 1597 (Rev 11/2007)

OMB No. 0651-0055 (Exp 10/31/2021)

Section 7 Request Form

To the Commissioner for Trademarks:

The registrant requests the following amendment(s) to registration no. 5518140 KERENDIA(Standard Characters, see http://uspto.report/TM/87700817/mark.png) has been amended as follows:

EXPLANATION OF FILING
This Request is being made to amend and restrict the identification of goods as identified in the subject registration. Registrant requests that the identification of goods be amended from  "Veterinary pharmaceutical preparations for the treatment of renal, cardiovascular, ophthalmic, liver, pulmonary, metabolic, and vascular diseases and fibrosis" to "Pharmaceutical preparations for the treatment of renal, cardiovascular, ophthalmic, liver, pulmonary, metabolic, and vascular diseases and fibrosis except neurological and oncological diseases".  

CLASSIFICATION AND LISTING OF GOODS/SERVICES
Registrant proposes to amend the following class of goods/services in the application:
Current: Class 005 for Veterinary pharmaceutical preparations for the treatment of renal, cardiovascular, ophthalmic, liver, pulmonary, metabolic, and vascular diseases and fibrosis; (Based on 44(e)) Veterinary pharmaceutical preparations for the treatment of renal, cardiovascular, ophthalmic, liver, pulmonary, metabolic, and vascular diseases and fibrosis
Original Filing Basis:
Filing Basis: Section 44(e), Based on Foreign Registration: Registrant has a bona fide intention to use the mark in commerce on or in connection with the identified goods and /or services, and submits a copy of [ European Union Trademark - EUTM registration number 016897721 registered 10/20/2017 with a renewal date of __________ and an expiration date of 06/22/2027 ], and translation thereof, if appropriate. 15 U.S.C. Section 1126(e), as amended.

Proposed: Class 005 for Pharmaceutical preparations for the treatment of renal, cardiovascular, ophthalmic, liver, pulmonary, metabolic, and vascular diseases and fibrosis except neurological and oncological diseases
Filing Basis: Section 44(e), Based on Foreign Registration: Registrant has a bona fide intention to use the mark in commerce on or in connection with the identified goods and /or services, and will submit a copy of [ European Union Trademark - EUTM registration number 016897721 registered 10/20/2017 with a renewal date of __________ and an expiration date of 06/22/2027 ], and translation thereof, if appropriate, before the application may proceed to registration. 15 U.S.C. Section 1126(e), as amended.

OWNER AND/OR ENTITY INFORMATION
Registrant proposes to amend the following:
Current: Bayer Aktiengesellschaft a(n) aktiengesellschaft, legally organized under the laws of Germany, having an address of
      Kaiser-Wilhelm-Allee
      51373 Leverkusen,
      Germany
Proposed: Bayer Aktiengesellschaft, aktiengesellschaft legally organized under the laws of Germany, having an address of

      Kaiser-Wilhelm-Allee
      51373 Leverkusen, 51373
      Germany


ATTORNEY INFORMATION
Registrant proposes to amend the following:
Current: Vanessa A. Ignacio One Lowenstein Drive lstrademark@lowenstein.com Roseland New Jersey United States 07068
Proposed: Vanessa A. Ignacio of Lowenstein Sandler LLP, having an address of One Lowenstein Drive lstrademark@lowenstein.com Roseland, New Jersey United States 07068, whose e-mail address is bayertrademarkus@bayer.com, whose phone number is 973-422-6426 and whose fax number is 973-422-6427.



CORRESPONDENCE ADDRESS CHANGE
Registrant proposes to amend the following:
Current: Vanessa A. Ignacio One Lowenstein Drive lstrademark@lowenstein.com Roseland New Jersey United States 07068
Proposed: Vanessa A. Ignacio of Lowenstein Sandler LLP, having an address of One Lowenstein Drive lstrademark@lowenstein.com Roseland, New Jersey United States 07068, whose e-mail address is bayertrademarkus@bayer.com; lstrademark@lowenstein.com, whose phone number is 973-422-6426 and whose fax number is 973-422-6427.


FEE(S)
Fee(s) in the amount of $100 is being submitted.

SIGNATURE(S)
Declaration Signature
The signatory being warned that willful false statements and the like are punishable by fine or imprisonment, or both, under 18 U.S.C. § 1001, and that such willful false statements and the like may jeopardize the validity of this submission, declares that all statements made of his/her own knowledge are true and all statements made on information and belief are believed to be true.

Signature: /Vanessa A. Ignacio/      Date: 04/25/2019
Signatory's Name: Vanessa A. Ignacio
Signatory's Position: Attorney of Record, NJ Bar Member
Signatory's Phone: 973-422-6426

Request Signature
Signature: /Vanessa A. Ignacio/     Date: 04/25/2019
Signatory's Name: Vanessa A. Ignacio
Signatory's Position: Attorney of Record, NJ Bar Member

Signatory's Phone: 973-422-6426

The signatory has confirmed that he/she is an attorney who is a member in good standing of the bar of the highest court of a U.S. state, which includes the District of Columbia, Puerto Rico, and other federal territories and possessions; and he/she is currently the owner's/holder's attorney or an associate thereof; and to the best of his/her knowledge, if prior to his/her appointment another U.S. attorney or a Canadian attorney/agent not currently associated with his/her company/firm previously represented the registrant in this matter: (1) the owner/holder has filed or is concurrently filing a signed revocation of or substitute power of attorney with the USPTO; (2) the USPTO has granted the request of the prior representative to withdraw; (3) the owner/holder has filed a power of attorney appointing him/her in this matter; or (4) the owner's/holder's appointed U.S. attorney or Canadian attorney/agent has filed a power of attorney appointing him/her as an associate attorney in this matter.

The applicant is NOT filing a Declaration of Use of Mark under Section 8; a Combined Declaration of Use of Mark under Sections 8 & 15; or a Combined Declaration of Use of Mark/Application for Renewal of Registration of Mark under Sections 8 & 9 in conjunction with this Section 7 Request.

Mailing Address:    Vanessa A. Ignacio
   Lowenstein Sandler LLP
   lstrademark@lowenstein.com
   One Lowenstein Drive
   Roseland, New Jersey 07068
        
RAM Sale Number: 5518140
RAM Accounting Date: 04/25/2019
        
Serial Number: 87700817
Internet Transmission Date: Thu Apr 25 10:01:22 EDT 2019
TEAS Stamp: USPTO/S7R-XXX.XXX.XXX.XXX-20190425100122
909969-5518140-6205ba4cc25ecf5307644a7e9
839c8fa5ff991b800d4b188660648043e06044cb
-CC-11041-20190424093108869923